Amp Capital Investors LTD Has Trimmed By $2.73 Million Its Telefonica S A (TEF) Position; 7 Analysts Are Bullish Intersect ENT, Inc. (XENT) Last Week

January 9, 2018 - By Richard Conner

Among 9 analysts covering Intersect ENT (NASDAQ:XENT), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Intersect ENT had 20 analyst reports since August 17, 2015 according to SRatingsIntel. As per Thursday, October 1, the company rating was maintained by Canaccord Genuity. The stock of Intersect ENT, Inc. (NASDAQ:XENT) earned “Outperform” rating by Northland Capital on Tuesday, March 29. Canaccord Genuity maintained the stock with “Buy” rating in Wednesday, December 6 report. The stock of Intersect ENT, Inc. (NASDAQ:XENT) has “Buy” rating given on Thursday, January 4 by Canaccord Genuity. The firm has “Overweight” rating by JP Morgan given on Tuesday, January 2. JP Morgan downgraded Intersect ENT, Inc. (NASDAQ:XENT) on Wednesday, November 2 to “Neutral” rating. As per Wednesday, August 2, the company rating was maintained by Northland Capital. The rating was maintained by Canaccord Genuity with “Buy” on Monday, August 17. The rating was maintained by Deutsche Bank on Wednesday, August 2 with “Buy”. The rating was maintained by Canaccord Genuity with “Buy” on Monday, October 16. See Intersect ENT, Inc. (NASDAQ:XENT) latest ratings:

04/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $43.0 Maintain
02/01/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Overweight Upgrade
06/12/2017 Broker: Canaccord Genuity Rating: Buy New Target: $36.0 Maintain
06/11/2017 Broker: BTIG Research Rating: Hold
16/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $37.0 Maintain
13/09/2017 Broker: Canaccord Genuity Rating: Buy Old Target: $32 New Target: $37 Maintain
21/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $35.0 Maintain
01/08/2017 Broker: Canaccord Genuity Rating: Buy New Target: $32.0000
02/08/2017 Broker: Northland Capital Rating: Hold New Target: $25.0000 Maintain
02/08/2017 Broker: Deutsche Bank Rating: Buy Old Target: $27 New Target: $31 Maintain

Amp Capital Investors Ltd decreased Telefonica S A (TEF) stake by 89.42% reported in 2017Q3 SEC filing. Amp Capital Investors Ltd sold 272,827 shares as Telefonica S A (TEF)’s stock rose 12.97%. The Amp Capital Investors Ltd holds 32,284 shares with $348,000 value, down from 305,111 last quarter. Telefonica S A now has $50.35 billion valuation. The stock decreased 0.60% or $0.06 during the last trading session, reaching $9.94. About 601,571 shares traded. Telefónica, S.A. (NYSE:TEF) has risen 9.21% since January 9, 2017 and is uptrending. It has underperformed by 7.49% the S&P500.

The stock increased 1.65% or $0.56 during the last trading session, reaching $34.66. About 68,090 shares traded. Intersect ENT, Inc. (NASDAQ:XENT) has risen 79.98% since January 9, 2017 and is uptrending. It has outperformed by 63.28% the S&P500.

Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. The company has market cap of $1.02 billion. It offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It currently has negative earnings. The firm is also developing RESOLVE, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: